ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Prevalence and Clinically Related Factors of Hypertriglyceridemia in Patients with Bipolar Disorder in Anhui Province, China.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The prevalence of comorbid hypertriglyceridemia in patients with bipolar disorder has received international attention. This study aims to explore the prevalence and clinical factors of comorbid hypertriglyceridemia in patients with bipolar disorder (BD) in Anhui, China. Patients and Methods: A total of 1072 patients with bipolar disorder were recruited from a large specialized hospital in Anhui, China. Demographic and clinical data were collected. Univariate and multivariate regression analyses were performed to assess the association between hypertriglyceridemia and various clinical variables. Results: The prevalence of hypertriglyceridemia in patients with bipolar disorder in Anhui Province was 22.6%. Compared with patients without hypertriglyceridemia, patients with hypertriglyceridemia were older, and had higher body mass index (BMI), blood glucose, total cholesterol, alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT) and uric acid levels, and lower high-density lipoprotein level. Multiple Logistic regression analysis showed that BMI (OR=1.51, p<0.001, 95% CI=1.23-1.84), blood glucose (OR=1.21, p<0.001, 95% CI=1.09-1.33), total cholesterol (OR=2.88, p<0.001, 95% CI=2.34-3.55) were positively associated with the risk of hypertriglyceridemia, while high-density lipoprotein cholesterol (OR=0.07, p<0.001, 95% CI=0.03-0.15) showed the opposite association. The nomogram developed from these findings demonstrates an area under the curve (AUC) of 0.803 (95% CI: 0.772-0.834), with a sensitivity of 0.770 and a specificity of 0.727. Consequently, it serves as an effective instrument for assessing the risk of hypertriglyceridemia. Conclusion: The prevalence of hypertriglyceridemia in patients with bipolar disorder is higher than that in the general population in Anhui, China, and its prevalence is related to BMI, blood glucose and other factors, which needs to be paid attention to and relevant measures should be taken.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.